BioAge Labs, Inc.

Q2 2026 13F Holders

Symbol: BIOA
CUSIP: 09077V100
Type: Equity
Class: COM
Num filings: 163
Total reported value, excl. options: $925 M

Compare 2026 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type